Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


InnaVirVax SA

Latest From LightLab Imaging Inc.

A Bright Future For Optical Imaging

One bright spot emerging in this otherwise lackluster economy is the market for optical imaging technologies. Optical imaging encompasses a wide array of current and emerging techniques that use light as the primary imaging modality to characterize local anatomy down to cellular and molecular levels.

Medical Device Europe

Device M&A Poised For A Strong Year

For the first time in five years, large cap, mid cap and financial buyers are all showing a willingness to acquire medical device companies thanks to improving credit markets and strong cash reserves.
Medical Device United States

On The Hunt For Vulnerable Plaque InfraReDx Improves Stenting Safety

Whatever happened to vulnerable plaque? More than a decade ago, vulnerable plaque was a hot topic that was hoped would explain many incidents of sudden cardiac death in patients without other symptoms of coronary artery disease. While many experts believe the theory underlying this concept remains sound, proving its validity and then developing both diagnostic tools to identify what have been called "vulnerable patients" and then therapeutic devices to treat them has turned out to be a difficult and lengthy challenge that remains unsolved. InfraReDx Inc. remains active in this area, and according to CEO and founder James Muller, MD, is closing in on a solution. InfraReDx recently raised $21 million in its Series D financing round.
Medical Device Platform Technologies

Stryker And St. Jude Acquisitions Signal Year-end Uptick In Device M&A

The M&A market for medtech companies had already slowly started to climb off the mat after last year's collapse when Stryker and St. Jude Medical closed on two $1 billion-plus acquisitions. Still, Stryker's bid to acquire the neurovascular business of Boston Scientific and St. Jude's offer for structural heart disease company AGA Medical demonstrate how deep strategic acquirers are willing to dig to establish themselves in new markets.The combined price tag of $2.7 billion guaranteed that 2010 will be a better year for medical device mergers and acquisitions than 2009, at least as measured by disclosed prices paid.
Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • InnaVirVax SA
  • Senior Management
  • Joel Crouzet, CEO
    Nathalie Baran, Dir. Finance & Ops.
    Raphael H Tsong Fang, Assoc. CMO
  • Contact Info
  • InnaVirVax SA
    Phone: 1 80 85 60 83
    4 rue Pierre Fontaine
    Evry, 91058